Conditions: Healthy
Keywords: Healthy Volunteers
Allocation: RANDOMIZED | Intervention model: CROSSOVER
Enrollment: 48
Healthy volunteers: yes

Brief summary:
This is a Phase 4, single center, open label, 4 period, 2 treatment, crossover, drug-drug interaction study.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Warfarin intervention 2: Warfarin 5mg + Rosuvastatin 40 mg once daily (QD) intervention 3: Warfarin 5 mg + Pitavastatin 4mg once daily (QD)
Intervention descriptions: intervention 1: Warfarin 5 mg once daily intervention 2: Warfarin 5mg + Rosuvastatin 40 mg once daily (QD) intervention 3: Warfarin 5 mg + Pitavastatin 4mg

Protocol document: